MedLife Medical System announces the completion of the acquisition of

majority stake in Pharmachem Distributie

  • This transaction will help MedLife group strengthen its presence in the pharma segment
  • The group aims to develop the online pharmacy segment, but also to optimize the procurement system at group level, for its own network of pharmacies and hospitals

Bucharest, July 23, 2021: MedLife Medical System announces the completion of the acquisition of the package of 75% shares of Pharmachem Distribuţie SRL. It is one of the largest acquisitions of the group in recent years.

Pharmachem has been operating on the pharmaceutical distribution services market for 16 years, being an important player, with a network of warehouses in Bucharest and throughout the country. At the level of 2019, the pharmaceutical distribution company registered a turnover of 83.4 million lei, increasing by 30% compared to previous year.

The management of Pharmachem will remain entirely in the hands of the current owners, who have the necessary know-how to properly manage the business and accelerate its growth.

In terms of M&A activity, MedLife Group is the company with the greatest expertise in acquiring and integrating a group of medical companies, reaching a portfolio of 32 acquisitions.

About MedLife Medical System:

MedLife Medical System started 26 years ago, has developed healthily and has become the largest provider of private medical services in Romania. Romanian entrepreneurs, who founded this company, invested and got involved to change the Romanian health system, believed in innovation and dared to aim as high as possible, to offer Romanian patients qualitative services, professionalism, care and respect for their needs.

The company operates the largest network of clinics, one of the largest networks of medical laboratories, general and specialized hospitals and has the largest corporate clients base for Health Prevention Packages in the country. It is also one of the largest private healthcare providers in Central and Eastern Europe in terms of sales.

MedLife Group has a history of success in terms of both organic growth and by acquisitions. Strong and experienced management team, was able to create and manage these growth opportunities, gaining valuable knowledge and experience, which allows to find the best way to successfully continue the expansion.

Being a Romanian company with a tradition, MedLife chose to be listed on the Romanian Stock Exchange, being a model for listings on the local capital market. It has opened up new horizons, and through the corporate governance it has implemented, has inspired other local companies to embark on this path and help develop the Romanian capital and economy. The shares issued by MedLife SA are admitted to trading on the regulated spot market administered by the Bucharest Stock Exchange, Premium Category, with the trading symbol ″ M ″.

During the pandemic, MedLife managed to play a key role in society and gain a detached leadership status in pandemic monitoring through active involvement in research activities.

The company continues to invest in projects in technology and infrastructure, with impact on the local community. It creates jobs and develops an ecosystem that contributes to the development and maintenance of a healthy Romania.

Attachments

  • Original document
  • Permalink

Disclaimer

Med Life SA published this content on 27 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 July 2021 00:07:02 UTC.